Illumina - LeanGene Partnership
01 Jan 2021
LeanGene (LGn) is pleased to announce a strategic partnership with Illumina, the global leader in DNA Sequencing and Array-Based Technologies, who dominates the largest share globally with thousands of published papers’ data extracted from illlumina’s platforms that serves researchers, patients and humanity in general.
The new model of collaboration entitles LeanGene to promote and support Illumina full portfolio in Jordan and Iraq through a dedicated team certified by illumina to be closer to you more than ever with all innovative solutions and support for all of your needs.
Mohammad Abahreh, Managing Director of LeanGene says
this new partnership will give us the opportunity to make NGS technology accessible and affordable to everyone, empowering researchers to experience NGS, to better serve and support healthcare professionals
Illumina, inc (NASDAQ:ILMN) is improving human health by unlocking the power of the genome. Illumina focus on innovation has established them as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Illumina products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
About LeanGene, ref. leangene-jo.com
In Touch With TOOMORROW!
Regional distribution based company that is pioneer in adopting innovative and state of art technologies. LGn serves the Clinical & Biomedical sectors and has started from a high level due to a solid and long term experienced team who also enjoys strong links with potential clients and is prepared to take the business and partners to subsequent levels.
